Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Brainstorm Cell Therapuetics Inc (NASDAQ:BCLI)

3.96
Delayed Data
As of 10:11am ET
 +0.0101 / +0.26%
Today’s Change
2.06
Today|||52-Week Range
4.70
+55.91%
Year-to-Date
No recent news for Brainstorm Cell Therapuetics Inc.

Today’s Trading

Previous close3.95
Today’s open3.96
Day’s range3.95 - 3.99
Volume2,297
Average volume (3 months)221,009
Market cap$73.8M
Dividend yield--
Data as of 10:11am ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+32.35%
Earnings growth (this year)+34.78%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book5.21

Competitors

 Today’s
change
Today’s
% change
AEZSAEterna Zentaris Inc+0.13+4.55%
RKDAArcadia Biosciences ...+0.00+0.57%
HTGMHTG Molecular Diagno...+7.47+190.08%
PRTOProteon Therapeutics...+0.02+1.61%
Data as of 10:26am ET, 03/24/2017

Financials

Next reporting dateMarch 30, 2017
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$0.00
Annual profit (last year)-$8.5M
Net profit margin--

Profile

Sector
Electronic Technology
Industry
Computer Peripherals
President &
Chief Executive Officer
Chaim Lebovits
Chief Operating &
Medical Officer
Ralph Z. Kern
Corporate headquarters
Hackensack, New Jersey

Forecasts


Search for Jobs